API's
Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients
Metoprolol Succinate SR Pellets are formulated to provide sustained release of Metoprolol Succinate, a cardioselective β1-blocker commonly used in managing hypertension, angina pectoris, and heart failure. Using advanced multiparticulate technology and polymer coatings, these pellets ensure steady plasma drug levels over an extended period, improving therapeutic efficacy and patient adherence with once-daily dosing.
| Component | Function |
|---|---|
| Metoprolol Succinate | Active Pharmaceutical Ingredient (API) |
| Sugar Spheres / MCC Pellets | Inert core / Neutral starter spheres ensuring mechanical strength and uniform pellet size |
| Hypromellose (HPMC) | Binder for drug layering; compatible with aqueous processing |
| Ethyl Cellulose | Sustained-release polymer controlling drug diffusion and providing extended release |
| Eudragit RS / RL | Functional polymer to fine-tune release kinetics for tailored dissolution profiles |
| Triethyl Citrate (TEC) | Plasticizer to provide flexibility and prevent cracking of polymer coatings |
| Talc | Anti-adherent to reduce sticking during coating process |
| Colloidal Silicon Dioxide | Glidant and anti-adherent to improve flow and prevent agglomeration |
| Purified Water / Isopropyl Alcohol | Solvent system (evaporated during processing) used for layering and coating |
Salius Pharma offers Metoprolol Succinate SR Pellets manufactured in USFDA-approved, WHO-GMP, and ISO-certified facilities in India. Our production processes fully comply with international regulatory standards and incorporate advanced sustained-release and pelletization technologies to ensure uniform drug release and high-quality performance.
We provide customizable strengths and pellet sizes, enabling flexible formulation development for once-daily cardiovascular medications. These pellets are engineered for scalability, regulatory acceptance, and global export, making them an ideal choice for formulators and partners in regulated and semi-regulated markets.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Metoprolol Succinate SR Pellets or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
The pellets are engineered to provide controlled, extended drug release, ensuring consistent therapeutic effect and reducing the need for multiple daily doses.
Yes. Metoprolol SR Pellets are suitable for direct compression into tablets and capsule filling, offering flexibility in oral dosage form development.
Salius Pharma offers tailored drug loads, pellet size, coating types, and release profiles, allowing manufacturers to meet regional regulatory requirements and formulation needs.
Each batch is produced under GMP standards, tested for stability, content uniformity, and dissolution, and shipped with complete regulatory documentation (CoA, MSDS, stability data) for safe export.